T(9;22)

Clinical trials for T(9;22) explained in plain language.

Never miss a new study

Get alerted when new T(9;22) trials appear

Sign up with your email to follow new studies for T(9;22), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo attack on tough leukemia shows promise

Disease control Recruiting now

This study is testing a new combination of drugs for adults with a specific, aggressive type of leukemia (Philadelphia chromosome-positive ALL) that has come back or hasn't responded to other treatments. The treatment combines an immunotherapy drug that helps the immune system fi…

Matched conditions: T(9;22)

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 17, 2026 13:08 UTC

T(9;22)

Get alerted when new T(9;22) trials appear

New combo attack on tough leukemia shows promise